Metal ion metabolism： New ideas for the traditional Chinese medicine prevention and treatment of chronic liver disease

Xinhua GUO; Jiahui WANG; Xuelin DUAN; Yue PENG; Tiejian ZHAO; Yang ZHENG; Bin ZHAO

doi:10.12449/JCH240732

Volume 40 Issue 7

Jul. 2024

Turn off MathJax

Article Contents

Abstract

References

Article Navigation > Journal of Clinical Hepatology > 2024 > 40(7): 1498-1504

PDF( 1157 KB)

Metal ion metabolism： New ideas for the traditional Chinese medicine prevention and treatment of chronic liver disease

DOI: 10.12449/JCH240732

1a.
Ruikang Clinical Medical College Guangxi University of Chinese Medicine，Nanning 530222，China
1b.
College of Zhuang Medicine Guangxi University of Chinese Medicine，Nanning 530222，China
1c.
College of Basic Medical Sciences Guangxi University of Chinese Medicine，Nanning 530222，China
2.
Faculty of Chinese Medicine Science Guangxi University of Chinese Medicine，Nanning 530222，China

Research funding:

National Natural Science Foundation of China (82204755);

National Natural Science Foundation of China (81960751);

Guangxi Natural Youth Foundation (2023GXNSFBA026274);

Guangxi Natural Youth Foundation (2024GXNSFAA010235);

Guangxi University of Traditional Chinese Medicine Youth Foundation (2022QN008);

Research Project of Sains New Medical College, Guangxi University of Traditional Chinese Medicine (2023MS008);

Research Project of Sains New Medical College, Guangxi University of Traditional Chinese Medicine (2022CX004)

More Information

Corresponding author: ZHAO Bin， yixue960@163.com （ORCID： 0009-0009-9429-8381）
Received Date: 2024-02-07
Accepted Date: 2024-04-01
Published Date: 2024-07-25

Abstract

Abstract

Chronic liver disease （CLD） tends to have a high incidence rate and impose a serious burden on society and families. Studies have shown that metal ion metabolism is closely associated with CLD， and some Chinese herbal medicines can play a role in the prevention and treatment of CLD by regulating metal ion metabolism. At present， the synthetic drugs currently used for the treatment of CLD fail to achieve a satisfactory effect， and therefore， a variety of Chinese herbal medicines are being used as supplementary and alternative therapies for CLD. This article introduces the role of metal ion metabolism in CLD and the regulatory effect of Chinese herbal medicines and their active components on CLD， and the analysis shows that metal ion metabolism is expected to provide new ideas for the research on CLD and a theoretical basis for the clinical treatment of CLD. For the role of metal ion metabolism in the treatment of CLD， more prospective clinical study data are needed in the future to provide effective and safe treatment regimens for patients with CLD.
- Liver Diseases,
- Metal Ions,
- Drugs， Chinese Herbal

FullText(HTML)

References(55)

References

[1]	RODRÍGUEZ MJ, SABAJ M, TOLOSA G, et al. Maresin-1 prevents liver fibrosis by targeting Nrf2 and NF-κB, reducing oxidative stress and inflammation[J]. Cells, 2021, 10( 12): 3406. DOI: 10.3390/cells10123406.
[2]	WANG CY, BABITT JL. Liver iron sensing and body iron homeostasis[J]. Blood, 2019, 133( 1): 18- 29. DOI: 10.1182/blood-2018-06-815894.
[3]	LIU T, LIU YL, ZHANG FY, et al. Association of copper metabolism disorder with cell damage and liver diseases[J]. J Clin Hepatol, 2023, 39( 9): 2244- 2251. DOI: 10.3969/j.issn.1001-5256.2023.09.032. 柳涛, 刘雅丽, 张飞宇, 等. 铜代谢失调与细胞损伤及肝病的关系[J]. 临床肝胆病杂志, 2023, 39( 9): 2244- 2251. DOI: 10.3969/j.issn.1001-5256.2023.09.032.
[4]	HIMOTO T, MASAKI T. Associations between zinc deficiency and metabolic abnormalities in patients with chronic liver disease[J]. Nutrients, 2018, 10( 1): 88. DOI: 10.3390/nu10010088.
[5]	TIAN H, XIANG P, ZHOU WH, et al. Correlation between the physiological characteristics of magnesium and cirrhosis[J]. Hebei Med J, 2021, 43( 8): 1246- 1251. DOI: 10.3969/j.issn.1002-7386.2021.08.029. 田慧, 向平, 周卫华, 等. 镁离子的生理特点及与肝硬化的关系[J]. 河北医药, 2021, 43( 8): 1246- 1251. DOI: 10.3969/j.issn.1002-7386.2021.08.029.
[6]	OLIVA-VILARNAU N, HANKEOVA S, VORRINK SU, et al. Calcium signaling in liver injury and regeneration[J]. Front Med(Lausanne), 2018, 5: 192. DOI: 10.3389/fmed.2018.00192.
[7]	SI MJ. Research progress on the correlation between abnormal iron metabolism and liver diseases[J]. Med Equip, 2022, 35( 2): 188- 191. DOI: 10.3969/j.issn.1002-2376.2022.02.077. 司茂杰. 铁代谢异常与肝脏疾病相关性的研究进展[J]. 医疗装备, 2022, 35( 2): 188- 191. DOI: 10.3969/j.issn.1002-2376.2022.02.077.
[8]	ZHAO JY, LI YW, LI L. The role of iron and hepcidin in hepatic fibrosis[J]. Prog Physiol Sci, 2010, 41( 3): 183- 188. 赵晋英, 李艳伟, 李琳. 铁和铁调素在肝纤维化中的作用[J]. 生理科学进展, 2010, 41( 3): 183- 188.
[9]	SIKORSKA K, BERNAT A, WROBLEWSKA A. Molecular pathogenesis and clinical consequences of iron overload in liver cirrhosis[J]. Hepatobiliary Pancreat Dis Int, 2016, 15( 5): 461- 479. DOI: 10.1016/s1499-3872(16)60135-2.
[10]	KEITH B, JOHNSON RS, SIMON MC. HIF1α and HIF2α: Sibling rivalry in hypoxic tumour growth and progression[J]. Nat Rev Cancer, 2011, 12( 1): 9- 22. DOI: 10.1038/nrc3183.
[11]	ZHANG LJ, DAI XZ, WANG L, et al. Iron overload accelerated lipid metabolism disorder and liver injury in rats with non-alcoholic fatty liver disease[J]. Front Nutr, 2022, 9: 961892. DOI: 10.3389/fnut.2022.961892.
[12]	ZHANG LL, CHENG N, WANG X. Metabolic mechanism of copper and its toxic effect on liver[J]. Chin J Gastroenterol, 2016, 21( 12): 762- 764. DOI: 10.3969/j.issn.1008-7125.2016.12.016. 张亮亮, 程楠, 王训. 铜代谢机制及其对肝脏的毒性作用[J]. 胃肠病学, 2016, 21( 12): 762- 764. DOI: 10.3969/j.issn.1008-7125.2016.12.016.
[13]	LI YW, WAN XH, NING Q, et al. Excessive copper induces hepatocyte apoptosis and affects Bax and Bcl-2 expression in rat liver[J]. Chin J Contemp Pediatr, 2008, 10( 1): 42- 46. 李毓雯, 万小华, 宁琴, 等. 铜过量负荷导致肝细胞凋亡及其对Bax Bcl-2基因表达的影响[J]. 中国当代儿科杂志, 2008, 10( 1): 42- 46.
[14]	YI B, CHEN Y, LIANG XH, et al. Serum copper and zinc levels of liver disease[J]. Bull Hunan Med Univ, 2002, 27( 3): 295- 296. DOI: 10.3321/j.issn:1672-7347.2002.03.037. 易斌, 陈宇, 梁湘辉, 等. 肝病患者血清铜、锌含量研究[J]. 湖南医科大学学报, 2002, 27( 3): 295- 296. DOI: 10.3321/j.issn:1672-7347.2002.03.037.
[15]	GOU Y, ZHANG Y, QI JX, et al. Enhancing the copper(II) complexes cytotoxicity to cancer cells through bound to human serum albumin[J]. J Inorg Biochem, 2015, 144: 47- 55. DOI: 10.1016/j.jinorgbio.2014.12.012.
[16]	AIGNER E, STRASSER M, HAUFE H, et al. A role for low hepatic copper concentrations in nonalcoholic fatty liver disease[J]. Am J Gastroenterol, 2010, 105( 9): 1978- 1985. DOI: 10.1038/ajg.2010.170.
[17]	GRÜNGREIFF K, REINHOLD D, WEDEMEYER H. The role of zinc in liver cirrhosis[J]. Ann Hepatol, 2016, 15( 1): 7- 16. DOI: 10.5604/16652681.1184191.
[18]	LIUZZI JP, COUSINS RJ. Mammalian zinc transporters[J]. Annu Rev Nutr, 2004, 24: 151- 172. DOI: 10.1146/annurev.nutr.24.012003.132402.
[19]	KOHGO Y, IKUTA K, OHTAKE T, et al. Iron overload and cofactors with special reference to alcohol, hepatitis C virus infection and steatosis/insulin resistance[J]. World J Gastroenterol, 2007, 13( 35): 4699- 4706. DOI: 10.3748/wjg.v13.i35.4699.
[20]	GRÜNGREIFF K, GOTTSTEIN T, REINHOLD D, et al. Albumin substitution in decompensated liver cirrhosis: Don’t forget zinc[J]. Nutrients, 2021, 13( 11): 4011. DOI: 10.3390/nu13114011.
[21]	WEAVER BP, ZHANG YX, HISCOX S, et al. Zip4(Slc39a4) expression is activated in hepatocellular carcinomas and functions to repress apoptosis, enhance cell cycle and increase migration[J]. PLoS One, 2010, 5( 10): e13158. DOI: 10.1371/journal.pone.0013158.
[22]	LIN CC, HUANG JF, TSAI LY, et al. Selenium, iron, copper, and zinc levels and copper-to-zinc ratios in serum of patients at different stages of viral hepatic diseases[J]. Biol Trace Elem Res, 2006, 109( 1): 15- 24. DOI: 10.1385/BTER:109:1:015.
[23]	KODAMA H, TANAKA M, NAITO Y, et al. Japan’s practical guidelines for zinc deficiency with a particular focus on taste disorders, inflammatory bowel disease, and liver cirrhosis[J]. Int J Mol Sci, 2020, 21( 8): 2941. DOI: 10.3390/ijms21082941.
[24]	ROMANI AM. Magnesium homeostasis and alcohol consumption[J]. Magnes Res, 2008, 21( 4): 197- 204.
[25]	KABE Y, ANDO K, HIRAO S, et al. Redox regulation of NF-kappaB activation: Distinct redox regulation between the cytoplasm and the nucleus[J]. Antioxid Redox Signal, 2005, 7( 3-4): 395- 403. DOI: 10.1089/ars.2005.7.395.
[26]	LIU SJ, ZHANG HW, GU CY, et al. Associations between hepatitis B virus mutations and the risk of hepatocellular carcinoma: A meta-analysis[J]. J Natl Cancer Inst, 2009, 101( 15): 1066- 1082. DOI: 10.1093/jnci/djp180.
[27]	LI Z, ZHENG YM. Effects of magnesium ions on the growth and proliferation of hepatocellular carcinoma cells and its mechanism[J]. Chin J Curr Adv Gen Surg, 2022, 25( 8): 608- 611, 617. DOI: 10.3969/j.issn.1009-9905.2022.08.004. 李征, 郑亚民. 金属镁离子对肝癌细胞生长增殖的影响及作用机制分析[J]. 中国现代普通外科进展, 2022, 25( 8): 608- 611, 617. DOI: 10.3969/j.issn.1009-9905.2022.08.004.
[28]	CUI JW, ZHANG J, CHENG WZ, et al. Clinical observation on the serum vitamin D level of the patients with chronic hepatitis B infection[J]. Chin J Integr Tradit West Med Liver Dis, 2017, 27( 5): 269- 271, 275. DOI: 10.3969/j.issn.1005-0264.2017.05.004. 崔剑巍, 张菁, 成伟忠, 等. 慢性HBV感染者血清维生素D水平的临床观察[J]. 中西医结合肝病杂志, 2017, 27( 5): 269- 271, 275. DOI: 10.3969/j.issn.1005-0264.2017.05.004.
[29]	XU XY, XIA SW, HUANG XJ, et al. Relationship between disease severity and serum calcium level in patients with chronic hepatitis B[J]. Chin J Lab Diagn, 2019, 23( 11): 1929- 1931. DOI: 10.3969/j.issn.1007-4287.2019.11.016. 徐晓义, 夏树伟, 黄小俊, 等. 慢性乙型肝炎患者病情严重程度与血清钙水平的关系[J]. 中国实验诊断学, 2019, 23( 11): 1929- 1931. DOI: 10.3969/j.issn.1007-4287.2019.11.016.
[30]	BIVER E, CALMY A, RIZZOLI R. Bone health in HIV and hepatitis B or C infections[J]. Ther Adv Musculoskelet Dis, 2017, 9( 1): 22- 34. DOI: 10.1177/1759720X16671927.
[31]	YIN LY, YIN J, CUI JF, et al. Association between serum calcium levels and the risk of liver cirrhosis[J]. Chin J Epidemiol, 2013, 34( 5): 457- 460. DOI: 10.3760/cma.j.issn.0254-6450.2013.05.010. 尹梁宇, 阴建, 崔剑峰, 等. 血清钙离子水平与肝硬化发病风险相关性研究[J]. 中华流行病学杂志, 2013, 34( 5): 457- 460. DOI: 10.3760/cma.j.issn.0254-6450.2013.05.010.
[32]	ZHANG YG, ZHANG G. The relationship between cell calcium and hepatic fibrosis[J]. Chin J N Clin Med, 2019, 12( 6): 683- 687. 张英耿, 张国. 细胞钙与肝纤维化的关系[J]. 中国临床新医学, 2019, 12( 6): 683- 687.
[33]	WU WJ, YANG MF, ZHU RM. Research progress on molecular biological mechanism of hepatic stellate cell activation[J]. J Clin Hepatol, 2009, 12( 4): 308- 311. DOI: 10.3969/j.issn.1672-5069.2009.04.028. 吴文娟, 杨妙芳, 朱人敏. 肝星状细胞活化的分子生物学机制研究进展[J]. 实用肝脏病杂志, 2009, 12( 4): 308- 311. DOI: 10.3969/j.issn.1672-5069.2009.04.028.
[34]	GUERRA MT, FLORENTINO RM, FRANCA A, et al. Expression of the type 3 InsP₃ receptor is a final common event in the development of hepatocellular carcinoma[J]. Gut, 2019, 68( 9): 1676- 1687. DOI: 10.1136/gutjnl-2018-317811.
[35]	YU ZY, WANG KS, REN YX, et al. Mechanism of action of curcumin in treatment of pancreatic cancer[J]. J Clin Hepatol, 2018, 34( 4): 900- 904. DOI: 10.3969/j.issn.1001-5256.2018.04.044. 俞泽元, 王科深, 任彦先, 等. 姜黄素抗胰腺癌的作用机制[J]. 临床肝胆病杂志, 2018, 34( 4): 900- 904. DOI: 10.3969/j.issn.1001-5256.2018.04.044.
[36]	RAINEY NE, MOUSTAPHA A, SARIC A, et al. Iron chelation by curcumin suppresses both curcumin-induced autophagy and cell death together with iron overload neoplastic transformation[J]. Cell Death Discov, 2019, 5: 150. DOI: 10.1038/s41420-019-0234-y.
[37]	SWAMY AV, GULLIAYA S, THIPPESWAMY A, et al. Cardioprotective effect of curcumin against doxorubicin-induced myocardial toxicity in albino rats[J]. Indian J Pharmacol, 2012, 44( 1): 73- 77. DOI: 10.4103/0253-7613.91871.
[38]	BADRIA FA, IBRAHIM AS, BADRIA AF, et al. Curcumin attenuates iron accumulation and oxidative stress in the liver and spleen of chronic iron-overloaded rats[J]. PLoS One, 2015, 10( 7): e0134156. DOI: 10.1371/journal.pone.0134156.
[39]	UEDA S, MASUTANI H, NAKAMURA H, et al. Redox control of cell death[J]. Antioxid Redox Signal, 2002, 4( 3): 405- 414. DOI: 10.1089/15230860260196209.
[40]	HUANG LL, SU J. Research progress on the mechanism of action and clinical application of Danshen[J]. Chin J Drug Abuse Prev Treat, 2023, 29( 6): 1002- 1006. DOI: 10.15900/j.cnki.zylf1995.2023.06.022. 黄丽丽, 苏静. 丹参的作用机制及临床应用研究进展[J]. 中国药物滥用防治杂志, 2023, 29( 6): 1002- 1006. DOI: 10.15900/j.cnki.zylf1995.2023.06.022.
[41]	YANG CL, WU J, CHEN YK. Protective effect of Salvia miltiorrhiza on high-copper diet-induced liver injury in rats[J]. J Tradit Chin Vet Med, 2016, 35( 6): 13- 16. DOI: 10.13823/j.cnki.jtcvm.2016.06.003. 杨成林, 邬静, 陈宇科. 丹参对铜诱导大鼠肝损伤的保护作用研究[J]. 中兽医医药杂志, 2016, 35( 6): 13- 16. DOI: 10.13823/j.cnki.jtcvm.2016.06.003.
[42]	FANG AP, CHEN PY, WANG XY, et al. Serum copper and zinc levels at diagnosis and hepatocellular carcinoma survival in the Guangdong Liver Cancer Cohort[J]. Int J Cancer, 2019, 144( 11): 2823- 2832. DOI: 10.1002/ijc.31991.
[43]	ALEXANDER JL, WILSON ID, TEARE J, et al. Gut microbiota modulation of chemotherapy efficacy and toxicity[J]. Nat Rev Gastroenterol Hepatol, 2017, 14( 6): 356- 365. DOI: 10.1038/nrgastro.2017.20.
[44]	SHEN L, JI HF. Bidirectional interactions between dietary curcumin and gut microbiota[J]. Crit Rev Food Sci Nutr, 2019, 59( 18): 2896- 2902. DOI: 10.1080/10408398.2018.1478388.
[45]	VINOD BS, ANTONY J, NAIR HH, et al. Mechanistic evaluation of the signaling events regulating curcumin-mediated chemosensitization of breast cancer cells to 5-fluorouracil[J]. Cell Death Dis, 2013, 4( 2): e505. DOI: 10.1038/cddis.2013.26.
[46]	WU RH, MEI XT, YE YB, et al. Zn(II)-curcumin solid dispersion impairs hepatocellular carcinoma growth and enhances chemotherapy by modulating gut microbiota-mediated zinc homeostasis[J]. Pharmacol Res, 2019, 150: 104454. DOI: 10.1016/j.phrs.2019.104454.
[47]	MENG ZQ. Study on the mechanism of apigenin alleviates liver injury induced by high fat diet through activating autophagy[D]. Changchun: Jilin University, 2023. 孟卓群. 芹菜素激活自噬缓解高脂饮食所致肝损伤的作用机制研究[D]. 长春: 吉林大学, 2023.
[48]	XU XR, LI M, CHEN WW, et al. Apigenin attenuates oxidative injury in ARPE-19 cells thorough activation of Nrf2 pathway[J]. Oxid Med Cell Longev, 2016, 2016: 4378461. DOI: 10.1155/2016/4378461.
[49]	PAN HY, WANG FG, ZHUANG RX, et al. Study on preparation of apigenin-magnesium complex[J]. Chin Arch Tradit Chin Med, 2014, 32( 2): 337- 339. DOI: 10.13193/j.issn.1673-7717.2014.02.039. 潘红英, 王福根, 庄让笑, 等. 芹菜素镁制备工艺的研究[J]. 中华中医药学刊, 2014, 32( 2): 337- 339. DOI: 10.13193/j.issn.1673-7717.2014.02.039.
[50]	PAN XW, SHAO YD, WANG FG, et al. Protective effect of apigenin magnesium complex on H₂O₂-induced oxidative stress and inflammatory responses in rat hepatic stellate cells[J]. Pharm Biol, 2020, 58( 1): 553- 560. DOI: 10.1080/13880209.2020.1772840.
[51]	GUO JZ, WAN F, LI X, et al. Study of the influence about the lipoperoxidation and zine, calcium content on Saikosaponin-d against liver fibrosis in rats[J]. Pharmacol Clin Chin Mater Med, 2009, 25( 3): 11- 14. 郭景珍, 万方, 李忻, 等. 柴胡皂苷d对肝纤维化大鼠脂质过氧化与微量元素锌、钙的影响[J]. 中药药理与临床, 2009, 25( 3): 11- 14.
[52]	ZHAO JL, MA LJ, QU M, et al. Effect of traditional Chinese medicine treatment on serum trace elements in rats with schistosomiasis hepatic fibrosis[J]. Shandong Med J, 2008, 48( 19): 38- 39. DOI: 10.3969/j.issn.1002-266X.2008.19.015. 赵建玲, 麻丽娟, 屈明, 等. 中药治疗对血吸虫肝纤维化鼠血清微量元素的影响[J]. 山东医药, 2008, 48( 19): 38- 39. DOI: 10.3969/j.issn.1002-266X.2008.19.015.
[53]	HU Y, WANG XL, LI DG, et al. Experimental study on the effects of Ca²⁺ antagonists on rat model of cirrhosis with portal hypertension[J]. Chin J Dig, 1995, 15( 2): 89- 91. 胡颖, 王秀玲, 李定国, 等. 钙拮抗剂对大鼠肝硬化模型门脉高压的实验研究[J]. 中华消化杂志, 1995, 15( 2): 89- 91.
[54]	LIAO Y, HE YH, LUO YW. Role of oxidative stress in acute liver injury[J]. J Clin Hepatol, 2022, 38( 10): 2402- 2407. DOI: 10.3969/j.issn.1001-5256.2022.10.039. 廖月, 何毅怀, 罗亚文. 氧化应激在急性肝损伤中的作用[J]. 临床肝胆病杂志, 2022, 38( 10): 2402- 2407. DOI: 10.3969/j.issn.1001-5256.2022.10.039.
[55]	SEKI E, SCHWABE RF. Hepatic inflammation and fibrosis: Functional links and key pathways[J]. Hepatology, 2015, 61( 3): 1066- 1079. DOI: 10.1002/hep.27332.

Relative Articles

[1]	Xueying LIU, Huihui SHI, Haowen WANG, Tao YANG. The material basis and toxic mechanism of herb-induced liver injury[J]. Journal of Clinical Hepatology, 2024, 40(8): 1512-1518. doi: 10.12449/JCH240802
[2]	Chenghai LIU. Research advances and challenges in herb-induced liver injury[J]. Journal of Clinical Hepatology, 2024, 40(8): 1505-1511. doi: 10.12449/JCH240801
[3]	Yinuo DONG, Yang ZHI, Jieting TANG, Yimin MAO. Diagnosis of herb-induced liver injury： Challenges in practice[J]. Journal of Clinical Hepatology, 2024, 40(8): 1533-1537. doi: 10.12449/JCH240805
[4]	Tingting HE, Zhaofang BAI, Jiabo WANG, Xiaohe XIAO. Phenotypic characteristics and toxicological mechanisms of herb-induced liver injury[J]. Journal of Clinical Hepatology, 2024, 40(8): 1525-1532. doi: 10.12449/JCH240804
[5]	Xin SUN, Qiong LUO, Tao YANG, Chenghai. LIU. Management and treatment of herb-induced liver injury[J]. Journal of Clinical Hepatology, 2024, 40(8): 1538-1542. doi: 10.12449/JCH240806
[6]	Hui ZHENG, Rong SUN. Influence of combined drug administration on herb-induced liver injury[J]. Journal of Clinical Hepatology, 2024, 40(8): 1519-1524. doi: 10.12449/JCH240803
[7]	Laying ZHANG, Mingkai CHEN. Research advances in the mechanism of action of TRPV4 ion channel protein in liver diseases[J]. Journal of Clinical Hepatology, 2022, 38(1): 224-227. doi: 10.3969/j.issn.1001-5256.2022.01.040
[8]	Zhen LI, Yihao ZENG, Ke WANG, Kaiqiang WANG, Kexian YU. Research advances in the prevention and treatment of hepatic ischemia-reperfusion injury with traditional Chinese medicine components[J]. Journal of Clinical Hepatology, 2022, 38(2): 471-476. doi: 10.3969/j.issn.1001-5256.2022.02.044
[9]	Yang ShangQing, Yang DongLiang, Liu Jia. Role of matrix metalloproteinases-2 and matrix metalloproteinases-9 in the development and progression of chronic liver diseases[J]. Journal of Clinical Hepatology, 2020, 36(10): 2364-2369. doi: 10.3969/j.issn.1001-5256.2020.10.045
[10]	Luo Qiong, Zhu GeRui, Gu HongTu, Liu Kun, Chen GaoFeng, Xing Feng, Tao YanYan, Liu ChengHai. Liver histopathological features of patients with drug-induced liver injury due to Chinese herbal medicine or Western medicine: A comparative analysis of 50 cases[J]. Journal of Clinical Hepatology, 2020, 36(3): 596-601. doi: 10.3969/j.issn.1001-5256.2020.03.025
[11]	Chen Jun. Drug-induced liver injury caused by Chinese herbal medicine cannot be neglected[J]. Journal of Clinical Hepatology, 2018, 34(6): 1169-1171. doi: 10.3969/j.issn.1001-5256.2018.06.006
[12]	Liu ChengHai, Zhu ChunWu. Epidemic features, major causes, and diagnostic evaluation of herb-induced liver injury[J]. Journal of Clinical Hepatology, 2017, 33(5): 829-832. doi: 10.3969/j.issn.1001-5256.2017.05.007
[13]	Zhu Yun, Wang RuiLin, Sun XueYing, Yu SiMiao, Jing Jing, Wang JiaBo, He TingTing, Huang YiXue, Wang LiPing, Sun YongQiang. Guiding significance of Guideline for diagnosis and treatment of herb-induced liver injury in clinical diagnosis: a retrospective analysis[J]. Journal of Clinical Hepatology, 2016, 32(11): 2159-2162. doi: 10.3969/j.issn.1001-5256.2016.11.032
[14]	Branch of Hepatobiliary Diseases, China Association of Chinese Medicine, Branch of Chinese Patent Medicine, China Association of Chinese Medicine. Guideline for diagnosis and treatment of herb-induced liver injury[J]. Journal of Clinical Hepatology, 2016, 32(5): 835-843. doi: 10.3969/j.issn.1001-5256.2016.05.003
[15]	Wu XueQin, Cheng HongQiu, Lin ZheXuan, Han Ming. Expression of DMT1 and its significance in hepatocellular carcinoma[J]. Journal of Clinical Hepatology, 2015, 31(11): 1883-1885. doi: 10.3969/j.issn.1001-5256.2015.11.027
[16]	Li JingTao, Chang ZhanJie, Xi Qi, Liu YaZhu, Song ChunRong, Nan Ran, Li RiXiang, Wei HaiLiang, Yan ShuGuang. HCV culture system and its application in antiviral research on Chinese herb extracts in vitro[J]. Journal of Clinical Hepatology, 2015, 31(1): 115-117. doi: 10.3969/j.issn.1001-5256.2015.01.026
[17]	Meng ShengXi, Hu YiYang. Prevention and treatment of liver diseases by compatibility of effective traditional Chinese medicine components:review of research and prospect[J]. Journal of Clinical Hepatology, 2014, 30(4): 295-298. doi: 10.3969/j.issn.1001-5256.2014.04.002
[18]	Li Yang, Xu JianMing. Clinical analysis of 11 cases of hepatic veno-occlusive disease caused by Chinese herbal medicine[J]. Journal of Clinical Hepatology, 2011, 27(2): 140-142.

Supplements(0)

Cited By

Proportional views

Proportional views

通讯作者: 陈斌, bchen63@163.com

1.
沈阳化工大学材料科学与工程学院沈阳 110142

Figures(2)

Get Citation

PDF

XML

Article Metrics

Article views (412) PDF downloads(47)

Metal ion metabolism： New ideas for the traditional Chinese medicine prevention and treatment of chronic liver disease

DOI: 10.12449/JCH240732

Abstract

References

Relative Articles

Proportional views

Catalog

通讯作者: 陈斌, bchen63@163.com

Article Metrics

Proportional views

Related

Metal ion metabolism： New ideas for the traditional Chinese medicine prevention and treatment of chronic liver disease

DOI: 10.12449/JCH240732

Abstract

References

Relative Articles

Proportional views

Catalog

通讯作者: 陈斌, bchen63@163.com

Article Metrics

Proportional views

Related

About Journal

Submission Guideline

Journal Online

Hepatobiliary College

Guidelines

Export File

Citation

Format

Content